1. Home
  2. AMRX vs CIVI Comparison

AMRX vs CIVI Comparison

Compare AMRX & CIVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AMRX
  • CIVI
  • Stock Information
  • Founded
  • AMRX 2002
  • CIVI 1999
  • Country
  • AMRX United States
  • CIVI United States
  • Employees
  • AMRX N/A
  • CIVI N/A
  • Industry
  • AMRX Biotechnology: Pharmaceutical Preparations
  • CIVI Oil & Gas Production
  • Sector
  • AMRX Health Care
  • CIVI Energy
  • Exchange
  • AMRX Nasdaq
  • CIVI Nasdaq
  • Market Cap
  • AMRX 2.5B
  • CIVI 2.5B
  • IPO Year
  • AMRX N/A
  • CIVI 2011
  • Fundamental
  • Price
  • AMRX $8.23
  • CIVI $29.41
  • Analyst Decision
  • AMRX Strong Buy
  • CIVI Buy
  • Analyst Count
  • AMRX 4
  • CIVI 12
  • Target Price
  • AMRX $11.50
  • CIVI $46.60
  • AVG Volume (30 Days)
  • AMRX 1.9M
  • CIVI 2.8M
  • Earning Date
  • AMRX 08-08-2025
  • CIVI 07-31-2025
  • Dividend Yield
  • AMRX N/A
  • CIVI 10.26%
  • EPS Growth
  • AMRX N/A
  • CIVI 5.61
  • EPS
  • AMRX N/A
  • CIVI 8.73
  • Revenue
  • AMRX $2,830,186,000.00
  • CIVI $5,071,808,000.00
  • Revenue This Year
  • AMRX $9.84
  • CIVI N/A
  • Revenue Next Year
  • AMRX $7.33
  • CIVI N/A
  • P/E Ratio
  • AMRX N/A
  • CIVI $3.37
  • Revenue Growth
  • AMRX 13.42
  • CIVI 22.15
  • 52 Week Low
  • AMRX $6.32
  • CIVI $22.79
  • 52 Week High
  • AMRX $9.48
  • CIVI $74.04
  • Technical
  • Relative Strength Index (RSI)
  • AMRX 61.71
  • CIVI 41.70
  • Support Level
  • AMRX $8.05
  • CIVI $27.40
  • Resistance Level
  • AMRX $8.24
  • CIVI $33.34
  • Average True Range (ATR)
  • AMRX 0.21
  • CIVI 1.33
  • MACD
  • AMRX 0.03
  • CIVI -0.46
  • Stochastic Oscillator
  • AMRX 90.91
  • CIVI 7.96

About AMRX Amneal Pharmaceuticals Inc.

Amneal Pharmaceuticals Inc is a pharmaceutical company operating in the U.S., India, and Ireland. With three reportable segments; Affordable Medicines, Specialty, and AvKARE - It develops, manufactures, and distributes a diverse portfolio of essential medicines. The Affordable Medicines segment focuses on a wide range of dosage forms and delivery systems, contributing significantly to revenues. The Specialty segment promotes proprietary branded pharmaceuticals, particularly targeting the central nervous system and endocrine disorders. The AvKARE segment provides pharmaceuticals and medical products to governmental agencies, specializing in re-packaging and wholesale distribution, with a focus on offering consistent care and pricing to qualified entities.

About CIVI Civitas Resources Inc.

Civitas Resources Inc is an independent exploration and production company engaged in the acquisition, development, and production of oil and associated liquids-rich natural gas in the Rocky Mountain region, in the Denver-Julesburg Basin of Colorado - DJ Basin. The company's operations are focused on developing the horizontal Niobrara and Codell formations that have a low-cost structure, mature infrastructure, production efficiencies, multiple producing horizons, multiple service providers, established reserves, and prospective drilling opportunities.

Share on Social Networks: